Comparative study of immune moderating effects of transfer factor edvancd
- VernacularTitle:Трансфер фактор Эдвенсдийн дархлаа дэмжих чадамжийн харьцуулсан судалгаа
- Author:
Purevdulam L
1
;
Ariya D
1
Author Information
1. New Medical University
- Publication Type:Journal Article
- From:
Health Laboratory
2022;16(2):22-24
- CountryMongolia
- Language:Mongolian
-
Abstract:
The immunodeficiency is too common in whole the world including this country. The myocardial Infarct, stroke, atherosclerosis and many other disorders develops in fact secondary immune deficit of human being.
We aimed to study the immune stimulating capacity of transfer factor advanced which used more than 50 countries in the world as a strong immune modulator, comparatively with other commonly used convalescents in our traditional medicine like bargashun and altan gagnuur and their membrane pereoxidase potential as well.
For this study were used white mouse’s with 20-25g of weights. All mouse’s were taken orally 0.05g of transfer factor advanced during 3 days 2 times per day and at the end were injected with 0.2 ml - 10% fresh red cell of sheep once which chosen as T-cell dependent stimulator test antigen. 5 days later were examined spleen index and counted newly generated antibody titer against sheep red cell.
The study result show that under the influence of transfer factor advanced after immunization (by 100 mg/mouse sheep red cell), the amount of cytotoxic T lymphocyte (T killer) cells among whole T lymphocyte population in the spleen and nearby lymph nodes of white mouse’s were perceptibly increased (1.43-2.33 P<0.001). It gives to conclude transfer factor advanced should have high treatment effects for several cancers, chronic liver disorders with B and C viruses hepatitis, cirrhoses etc., which develops due to deficit of T killer cell.
- Full text:HL-2022-16(2)-22-24.pdf
